The largest pharmacovigilance analysis, Cazzola 2024 (251,145 FAERS reports across all approved GLP-1 RAs), identified disproportionate reporting signals for asthma-like events (ROR 1.63, 95% CI 1.411.88), bronchial hyperreactivity, and allergic respiratory symptoms [1]
It has to be a consistent thing to really build that clientele. At Savor, they try to have a little something for everyone: delicious, nutritious and in a palatable size
Skin Research and Technology, 27 (3), 299308.
Gastrointestinal adverse effectsincluding nausea (occurring in up to 43% of patients at higher doses), vomiting, diarrhea, and abdominal discomfortmay trigger or exacerbate anxiety symptoms in susceptible individuals